CRAC and SK Channels: Their Molecular Mechanisms Associated with Cancer Cell Development

Adéla Tiffner1, Valentina Hopl1, Isabella Derler1

  • 1Institute of Biophysics, JKU Life Science Center, Johannes Kepler University Linz, A-4020 Linz, Austria.

Cancers
|January 8, 2023
PubMed

Insights

Calcium (Ca2+) channels, Orai1 and SK3, are key regulators in cancer progression and metastasis. Understanding their co-regulation offers new therapeutic targets to combat cancer recurrence and mortality.

Area of Science:

  • Oncology
  • Molecular Biology
  • Ion Channel Physiology

Background:

  • Cancer remains a leading cause of mortality globally, with therapy resistance driving mortality.
  • Identifying novel molecular targets is crucial for improving cancer treatment outcomes.
  • Dysregulation of calcium (Ca2+) signaling is increasingly implicated in cancer development.

Purpose of the Study:

  • To elucidate the physiological role of Ca2+ in carcinogenesis.
  • To detail the structure/function of Orai1 and SK3 ion channels.
  • To explore the co-regulation of Orai1 and SK3 channels in cancer and identify knowledge gaps.

Main Methods:

  • Literature review and synthesis of existing research on Ca2+ signaling in cancer.
  • Analysis of the structure and function of Orai1 and SK3 channels.
  • Examination of the interplay between Orai1 and SK3 in various cancer types.

Main Results:

  • Ca2+ ions play a significant role in cancer cell development, proliferation, and migration.
  • The co-regulation of Orai1 and SK3 channels is linked to the invasion-metastasis cascade in breast and colon cancers.
  • The precise molecular mechanisms governing Orai1 and SK3 interplay remain incompletely understood.

Conclusions:

  • Orai1 and SK3 ion channels represent promising molecular targets for cancer therapy.
  • Further research is needed to fully understand the co-regulation of these channels for therapeutic development.
  • Targeting Ca2+ signaling pathways may offer novel strategies against cancer recurrence.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K